These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9382752)

  • 1. Potential of protein OprF of Pseudomonas in bivalent vaccines.
    Hancock RE; Wong R
    Behring Inst Mitt; 1997 Feb; (98):283-90. PubMed ID: 9382752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linker-insertion mutagenesis of Pseudomonas aeruginosa outer membrane protein OprF.
    Wong RS; Jost H; Hancock RE
    Mol Microbiol; 1993 Oct; 10(2):283-92. PubMed ID: 7934819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
    von Specht BU; Domdey H; Schödel F; Blum B; Lücking C; Knapp B; Muth G; Hungerer KD; Bröker M
    Behring Inst Mitt; 1994 Dec; (95):85-96. PubMed ID: 7538752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric influenza viruses incorporating epitopes of outer membrane protein F as a vaccine against pulmonary infection with Pseudomonas aeruginosa.
    Gilleland HE; Gilleland LB; Staczek J; Harty RN; Garcia-Sastre A; Engelhardt OG; Palese P
    Behring Inst Mitt; 1997 Feb; (98):291-301. PubMed ID: 9382753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the length of a malarial epitope on its antigenicity and immunogenicity in an epitope presentation system using the Pseudomonas aeruginosa outer membrane protein OprF as the carrier.
    Wong RS; Hancock RE
    FEMS Microbiol Lett; 1996 Jul; 140(2-3):209-14. PubMed ID: 8764483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hybrid outer membrane protein antigen for vaccination against Pseudomonas aeruginosa.
    Gabelsberger J; Knapp B; Bauersachs S; Enz UI; von Specht BU; Domdey H
    Behring Inst Mitt; 1997 Feb; (98):302-14. PubMed ID: 9382754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.
    Worgall S; Krause A; Rivara M; Hee KK; Vintayen EV; Hackett NR; Roelvink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
    J Clin Invest; 2005 May; 115(5):1281-9. PubMed ID: 15841217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa outer membrane protein OprF as an expression vector for foreign epitopes: the effects of positioning and length on the antigenicity of the epitope.
    Wong RS; Wirtz RA; Hancock RE
    Gene; 1995 May; 158(1):55-60. PubMed ID: 7540583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OprF/I-vaccinated sera inhibit binding of human interferon-gamma to Pseudomonas aeruginosa.
    Ding B; von Specht BU; Li Y
    Vaccine; 2010 Jun; 28(25):4119-22. PubMed ID: 20433804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
    Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa.
    Weimer ET; Ervin SE; Wozniak DJ; Mizel SB
    Vaccine; 2009 Nov; 27(48):6762-9. PubMed ID: 19744586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilin-based anti-Pseudomonas vaccines: latest developments and perspectives.
    Hahn H; Lane-Bell PM; Glasier LM; Nomellini JF; Bingle WH; Paranchych W; Smit J
    Behring Inst Mitt; 1997 Feb; (98):315-25. PubMed ID: 9382755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of the receptor binding domains of Pseudomonas aeruginosa pili strains PAK, PAO, KB7 and P1 to a cross-reactive antibody and receptor analog: implications for synthetic vaccine design.
    Campbell AP; Wong WY; Houston M; Schweizer F; Cachia PJ; Irvin RT; Hindsgaul O; Hodges RS; Sykes BD
    J Mol Biol; 1997 Mar; 267(2):382-402. PubMed ID: 9096233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation of Pseudomonas aeruginosa recombinant outer-membrane protein F and the study of its antigenic properties].
    Kaloshin AA; Zlygostev SA; Toropchina IuN; Kurbatova EA; Zverev VV; Mikhaĭlova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (5):50-3. PubMed ID: 16279535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections.
    Baumann U; Mansouri E; von Specht BU
    Vaccine; 2004 Feb; 22(7):840-7. PubMed ID: 15040936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
    von Specht B; Knapp B; Hungerer K; Lücking C; Schmitt A; Domdey H
    J Biotechnol; 1996 Jan; 44(1-3):145-53. PubMed ID: 8717398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosa.
    Price BM; Barten Legutki J; Galloway DR; von Specht BU; Gilleland LB; Gilleland HE; Staczek J
    FEMS Immunol Med Microbiol; 2002 Jun; 33(2):89-99. PubMed ID: 12052563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [[Vaccine development for P. aeruginosa: based on antigen cloning of clinical vaccines][].
    von Specht BU
    Zentralbl Chir; 1999; 124(4):298-302. PubMed ID: 10355084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.